Free Trial
TSE:TRL

Trilogy International Partners (TRL) Stock Price, News & Analysis

Trilogy International Partners logo

About Trilogy International Partners Stock (TSE:TRL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
239,293 shs
Average Volume
68,686 shs
Market Capitalization
C$21.27 million
P/E Ratio
0.04
Dividend Yield
704.17%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TRL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trilogy International Partners and its competitors with MarketBeat's FREE daily newsletter.

TRL Stock News Headlines

Trump’s $100 Trillion Land Rush Is On
What Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trillions in oil, gas, lithium, and land rights. Whitney Tilson breaks it all down, and shows how everyday Americans can grab a stake. His urgent new briefing explains "The US: IPO"... and how to get in before the looming federal deadline.
Trilogy International Partners Inc TRL.H
See More Headlines

TRL Stock Analysis - Frequently Asked Questions

Shares of TRL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Trilogy International Partners investors own include Acerus Pharmaceuticals (ASP), Millicom International Cellular (TIGO), Emera (EMA), Merck & Co., Inc. (MRK), NFI Group (NFI), (ONCYF) (ONCYF) and ARK Autonomous Technology & Robotics ETF (ARKQ).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Major
Sub-Industry
Healthcare
Current Symbol
TSE:TRL
Previous Symbol
TSE:AQX.A
CIK
N/A
Web
N/A
Fax
N/A
Employees
70,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
0.04
Forward P/E Ratio
N/A
P/E Growth
0.86
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.92
Quick Ratio
3.87

Sales & Book Value

Annual Sales
C$407.64 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.77
Book Value
C$0.38 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
88,628,000
Free Float
N/A
Market Cap
C$21.27 million
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (TSE:TRL) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners